Clinical Trial Update: Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of sunitinib with FOLFOX in patients with solid tumors; the trial is completed and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Neoplasms
• Neoplasms

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Sutent (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Colorectal Neoplasms, Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2009-12-09